Clinical Trial Update: Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

View source ↗

Summary

A completed clinical trial evaluating the sensitivity of the Clearview HIV 1/2 rapid test in adolescents aged 12-17.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Clearview HIV 1/2 Rapid Test (HIV-1/2 antibody rapid diagnostic test)

Snippet

Sponsor: Chembio Diagnostic Systems, Inc. | Conditions: HIV Infections | Status: COMPLETED